ADAR1 Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
143,917
-657,360
| -82% | -$1.91M | 0.06% | 121 |
|
|
2025
Q1 | $577K | Hold |
801,277
| – | – | 0.11% | 94 |
|
|
2024
Q4 | $825K | Buy |
801,277
+57,818
| +8% | +$59.6K | 0.16% | 85 |
|
|
2024
Q3 | $996K | Sell |
743,459
-175,470
| -19% | -$235K | 0.16% | 72 |
|
|
2024
Q2 | $1.19M | Sell |
918,929
-8,000
| -0.9% | -$10.4K | 0.23% | 55 |
|
|
2024
Q1 | $1.59M | Sell |
926,929
-140,782
| -13% | -$242K | 0.36% | 44 |
|
|
2023
Q4 | $1.57M | Buy |
+1,067,711
| New | +$1.57M | 0.56% | 31 |
|